期刊文献+

甲状腺乳头状癌相关基因BRAF研究的新进展 被引量:6

下载PDF
导出
摘要 甲状腺癌是常见的内分泌肿瘤,其组织学类型主要包括乳头状癌(PTC),滤泡状癌(FTC),未分化癌(ATC)和髓样癌(MTC),以PTC所占比例最大。过去几十年里整个西方世界甲状腺癌的发病率在增加。我国甲状腺癌的发病率由10/100万升到约30/100万至40/100万;
出处 《医学临床研究》 CAS 2013年第12期2484-2487,共4页 Journal of Clinical Research
  • 相关文献

参考文献38

  • 1Hundah l SA,Fleming ID,Fremgen AM. A National Cancer Data Vase report on 53,856 cases of thyroid carcinoma treated in the U.S.A 1985-1995[J].{H}CANCER,1998,(12):2638-2648.
  • 2应敏刚,陈建顺,肖景榕,陈增春,周衍.长乐市1988~2002年恶性肿瘤发病率时间趋势分析[J].中国肿瘤,2005,14(1):32-34. 被引量:21
  • 3Shuntaro I,Mikihaiu F,Yoshto U. B-raf,a new mem-ber of the raf family is activated by DNA rearrangement[J].{H}Molecular and Cellular Biology,1988,(6):2651-2654.
  • 4Davies H,Bignell GR,Cox C. Mutations of the BRAF gene in hum an cancer[J].{H}NATURE,2002,(6892):949-954.
  • 5Cohen Y,Rosenbaum E,Clark DP. Mutational analy-sis of BRAF in fine needle aspiration biopsies of the thyroid:A potential application for the preoperative assessment of thy-roid nodules[J].{H}Clinical Cancer Research,2004,(8):2761-2765.
  • 6Xing MZ,Westra WH,Tufano RP. BRAF mutation predict s a poorer clinical prognosis for papillary thyroid canc-er[J].{H}Journal of Clinical Endocrinology and Metabolism,2005,(12):6373-6379.
  • 7钱碧云,陈可欣,何敏,董淑芬,韩宏伟,雷蕾,王继芳.天津市区甲状腺癌流行状况调查[J].中国肿瘤临床,2005,32(4):218-221. 被引量:56
  • 8Davies H,Bignell GR,Cox C. Mutations of the BRAF gene in human cancer[J].{H}NATURE,2002,(6892):949-954.
  • 9Xing M. BRAF mutation in thyroid cancer[J].{H}Endocrine Related Cancer,2005,(2):245-262.
  • 10Xing M. Gene methylation in thyroid tumor genesis[J].{H}ENDOCRINOLOGY,2007,(3):948-953.

二级参考文献41

  • 1项永兵,金凡,袁剑敏,孙璐,高玉堂.肿瘤登记资料统计分析的微机实用软件[J].中国慢性病预防与控制,1994,2(2):74-76. 被引量:5
  • 2朱晓丽,周晓燕,朱雄增.甲状腺乳头状癌中BRAF^(V599E)点突变与RET/PTC融合基因的检测[J].中华病理学杂志,2005,34(5):270-274. 被引量:30
  • 3尹香利,张国昌,李锋,赵瑾,李洪安,梁伟华.MASA-PCR检测甲状腺乳头状癌中BRAF^(V600E)点突变的研究[J].石河子大学学报(自然科学版),2005,23(5):551-555. 被引量:4
  • 4Hundahl SA, Fleming ID, Fremgen AM, et al. A national cance data base report on 53 856 eases of thyroid carcinoma treated in the U. S, 1985-1995. Cancer,1998,83: 2638-2648.
  • 5Peyssonnaux C, Eychene A. The RAF/MEK/ERK pathway: new concepts of activation. Biol Cell ,2001,93: 53-62.
  • 6Duesbery NS, Webb CP, Vande Woude GF. MEK wars, a new front in the battle against cancer. Nat Med,1999,5 : 736-742.
  • 7Cohen Y, Rosenbaum E, Clark DP, et al. Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules, Clin Can Res,2004,10 : 2761-2765.
  • 8Xing MZ, Tufano RP, Tufaro AP, et al. Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J Clin Endocrinol Metab,2004,89 : 2867-2872.
  • 9Davies H, Bignell GR, Cox C,et al. Mutations of the BRAF gene in human cancer, Nature,2002,417-949.
  • 10Xing MZ. BRAF mutation in thyroid cancer. Endocrine-Related Cancer ,2005,12 : 245-262.

共引文献83

同被引文献38

引证文献6

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部